Newsletters

Global Life Science Business Partnering (GLSBP) - January 2023

Highlights of January 2023Sun Pharma acquires U.S.-based Concert Pharma for $576 million, to gain access to its experimental drug for treating patchy ...

Read More

Global Life Science Business Partnering (GLSBP) - December 2022

Highlights of December 2022Private equity giant Advent International will acquire a 50.1% stake in Suven Pharmaceuticals from Jasti family for nearly ...

Read More

Global Life Science Business Partnering (GLSBP) - November 2022

Highlights of November 2022Gland Pharma buys Cenexi Group for €120 Million.Mankind Pharma acquires majority stake in Upakarma Ayurveda.Lupin's Brazi...

Read More

Global Life Science Business Partnering (GLSBP) - October 2022

Highlights of October 2022Lupin Signs Agreement to Acquire Two Inhalation Brands from Sunovion.Hetero acquires Johnson & Johnson's manufacturing p...

Read More

Global Life Science Business Partnering (GLSBP) - September 2022

Highlights of September 2022Lupin, DKSH sign agreement to commercialize five biosimilar candidates in Philippines.Dr. Reddy’s Labs partners with IQV...

Read More

Global Life Science Business Partnering (GLSBP) - August 2022

Highlights of August 2022Aurobindo Pharma completes acquisition of 51% stake in GLS Pharma.Lupin and I’rom enter into exclusive licensing agreement ...

Read More

Global Life Science Business Partnering (GLSBP) - July 2022

Highlights of July 2022Dr. Reddy's Labs acquires injectable product portfolio from Eton Pharma.Aurigene inks drug discovery partnership with EQRx.Zena...

Read More

Global Life Science Business Partnering (GLSBP) - June 2022

Featured NewsDr. Reddy's Labs acquires injectable product portfolio from Eton Pharma.Cipla to acquire 21% stake in Achira Labs for Rs 25 crores.Glenma...

Read More

Global Life Science Business Partnering (GLSBP) - May 2022

Highlights of May 20221. Biocon Biologics may close $3.34 billion Viatris deal by end of June 2022. 2.    Eris Lifesciences acqui...

Read More

Global Life Science Business Partnering (GLSBP) - April 2022

Highlights of April 2022 1.      The Abu Dhabi Investment Authority (ADIA) to acquire about 3% in Intas Pharmaceutica...

Read More

×
Twitter